Boston University's D'Agostino to serve as NDAC chair through May 1997.
This article was originally published in The Tan Sheet
Executive Summary
NEW NDAC CHAIR D'AGOSTINO BRINGS WEALTH OF FDA ADVISORY CMTE. EXPERIENCE as he takes the reigns of FDA's Nonprescription Drugs Advisory Committee. Effective immediately, Ralph D'Agostino, PhD, Boston University, replaces outgoing chairman Randy Juhl, PhD, University of Pittsburgh, whose term as the original NDAC chair ended May 31. D'Agostino, 55, currently is a professor of mathematics/statistics at Boston University's College of Liberal Arts and School of Public Health and a professor at the Boston University School of Law.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning